Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Methods in Molecular Biology (Clifton, N.J.)|November 22, 2013
Isolation of melanoma cell subpopulations using negative selectionAna Slipicevic, Rajasekharan Somasundaram, Katrin Sproesser, et al.
Molecular Cancer Research : MCR|June 15, 2016
Targeting RRM2 and Mutant BRAF Is a Novel Combinatorial Strategy for MelanomaNail Fatkhutdinov, Katrin Sproesser, Clemens Krepler, et al.
Cancer Immunology, Immunotherapy : CII|December 25, 2007
Peptides mimicking GD2 ganglioside elicit cellular, humoral and tumor-protective immune responses in miceAssefa Wondimu, Tianqian Zhang, Thomas Kieber-Emmons, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2008
The mitogen-activated protein/extracellular signal-regulated kinase kinase inhibitor AZD6244 (ARRY-142886) induces growth arrest in melanoma cells and tumor regression when combined with docetaxelNikolas K Haass, Katrin Sproesser, Thiennga K Nguyen, et al.
Pigment Cell & Melanoma Research|October 27, 2010
PLX4032, a potent inhibitor of the B-Raf V600E oncogene, selectively inhibits V600E-positive melanomasJohn T Lee, Ling Li, Patricia A Brafford, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 10, 2003
Recombinant CD63/ME491/neuroglandular/NKI/C-3 antigen inhibits growth of established tumors in transgenic miceJian Li, Weiping Li, Shaohong Liang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2017
Acetylsalicylic Acid Governs the Effect of Sorafenib in RAS-Mutant CancersHeinz Hammerlindl, Dinoop Ravindran Menon, Sabrina Hammerlindl, et al.
Cancer Immunology, Immunotherapy : CII|March 22, 2003
Induction of cellular immunity by anti-idiotypic antibodies mimicking GD2 gangliosideSaroj Basak, Brigitte Birebent, Enkhtsetseg Purev, et al.
Nature|February 22, 2018
Corrigendum: Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistanceSydney M Shaffer, Margaret C Dunagin, Stefan R Torborg, et al.
Blood Advances|March 10, 2020
A novel C2 domain binding CD33xCD3 bispecific antibody with potent T-cell redirection activity against acute myeloid leukemiaPriyanka Nair-Gupta, Michael Diem, Dara Reeves, et al.
Pageof 3